K Number
K183291
Device Name
Supria True64 Whole-Body X-Ray CT System
Date Cleared
2019-02-01

(67 days)

Product Code
Regulation Number
892.1750
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Supria True64 System is indicated for head, whole body, and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, or dynamic modes. The volume datasets acquired by the Supria can be post processed by the system to provide additional information. Post processing capabilities included in the Supria software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering. Volume datasets acquired by the Supria can be transferred to external devices via a DICOM standard interface. The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.
Device Description
The Supria True64 is a multi-slice computed tomography system designed to perform multi-slice CT scanning supported by 64-detector technology. The system allows optimum clinical applications ranging from routine exams in response to the diversified circumstances in imaging whole body regions.
More Information

No
The summary describes standard CT imaging and post-processing techniques (CTA, MPR, volume rendering) without mentioning AI or ML.

No.

The device is an X-ray Computed Tomography system used for imaging and diagnosis, not for treating diseases or conditions.

Yes.

Explanation: The "Intended Use/Indications for Use" section states, "The device output can provide an aid to diagnosis when used by a qualified physician."

No

The device description clearly states it is a "multi-slice computed tomography system" and mentions hardware components like "64-detector technology." While it includes software for post-processing, it is fundamentally a hardware-based imaging system.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The Supria True64 System is an X-ray Computed Tomography (CT) system. It uses X-rays to create images of the inside of the body. This is an in vivo imaging technique, meaning it is performed on a living organism, not on samples taken from the body.
  • Intended Use: The intended use clearly states it is for "head, whole body, and vascular X-ray Computed Tomography applications." This involves imaging the patient directly.

Therefore, the Supria True64 System falls under the category of medical imaging devices, not In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

The Supria True64 System is indicated for head, whole body, and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, or dynamic modes. The volume datasets acquired by the Supria can be post processed by the system to provide additional information. Post processing capabilities included in the Supria software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering. Volume datasets acquired by the Supria can be transferred to external devices via a DICOM standard interface. The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.

Product codes

JAK

Device Description

The Supria True64 is a multi-slice computed tomography system designed to perform multi-slice CT scanning supported by 64-detector technology. The system allows optimum clinical applications ranging from routine exams in response to the diversified circumstances in imaging whole body regions.
The Supria True64 system uses 64-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator, X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles.
The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system.
The Supria True64 system consists of a Gantry, Operator's Workstation, Patient Table, High-Frequency X-ray Generator, and accessories.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

X-ray Computed Tomography

Anatomical Site

Head, whole body, and vascular

Indicated Patient Age Range

all ages

Intended User / Care Setting

qualified physician

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Validation Testing - Bench: Based on the results of the ECG Prospective Scan Performance Testing Report contained in Verification and Validation Documentation of Section 9, Hitachi judged that Supria True64 with ECG Prospective Scan (Axial) performs to specifications.
Validation Testing - Clinical: None required.
The analysis confirms the performance characteristics of the Supria True64 are comparable to the predicate device and support our conclusion that the subject system is substantially equivalent to Supria True64 Whole-body X-ray CT System (K171738).
This device complies with all applicable requirements for Dose Profile, Noise, Mean CT number and Uniformity, Spatial Resolution, Tomographic Section Thickness and Sensitivity Profile, Tomographic Plane Location, and CT dose index. Adding the ECG Prospective Scan (Axial) would not impact the results of the testing done in the original submission.
Noise, Mean CT number, Uniformity and Spatial Resolution test results for the Supria True64 Whole-body X-ray CT System (K171738) would not be effected by this feature.
the ECG Prospective Scan feature was subject to performance tests, which confirmed that the X-ray was in synchronization with the ECG trigger and the acquired images. The results confirmed that images which are synchronized with ECG R-wave signal can be acquired by using ECG Prospective Scan.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Supria True64 Whole-body X-ray CT System (K171738)

Reference Device(s)

HITACHI SCENARIA Wholebody X-ray CT System (K101888)

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1750 Computed tomography x-ray system.

(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath.

February 1, 2019

Hitachi Healthcare Americas % Mr. Aaron Pierce Director of Regulatory Affairs and Quality Assurance 1959 Summit Commerce Park TWINSBURG OH 44087

Re: K183291

Trade/Device Name: Supria True64 Whole-body X-ray CT System Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: Class II Product Code: JAK Dated: November 20, 2018 Received: November 26, 2018

Dear Mr. Pierce:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

1

requirements, including, but not limited to: registration and listing (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Use 2. Mils

for Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

2

510(k) Number (if known)K183291
Device NameSupria True64 Whole-body X-ray CT System
Indications for Use (Describe)The Supria True64 System is indicated for head, whole body, and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, or dynamic modes. The volume datasets acquired by the Supria can be post processed by the system to provide additional information. Post processing capabilities included in the Supria software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering. Volume datasets acquired by the Supria can be transferred to external devices via a DICOM standard interface. The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)□ Over-The-Counter Use (21 CFR 801 Subpart C)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

レート

3

Image /page/3/Picture/0 description: The image contains the word "HITACHI" in bold, black letters. Below the word "HITACHI" is the phrase "Inspire the Next" in a smaller, non-bold font. The word "Next" has a small red accent mark above the letter "t".

K183291

Section 5 510(k) Statement or Summary

Submitter Information

| Submitter: | Hitachi Healthcare Americas
1959 Summit Commerce Park
Twinsburg, Ohio 44087-2371 |
|-------------------|----------------------------------------------------------------------------------------|
| Contact: | Aaron Pierce |
| Telephone number: | 330-425-1313 |
| Telephone number: | 330-963-0749 |
| E-mail: | piercea@hitachihealthcare.com |
| Date: | November 20, 2018 |

Subject Device Name

Trade/Proprietary Name:Supria True64 Whole-body X-ray CT System
Regulation Number:21 CFR 892.1750
Regulation Name:Computed tomography x-ray system
Product CodeJAK, System, X-Ray, Tomography, Computed
ClassII
PanelRadiology

Predicate Device Name

Predicate Device(s):Supria True64 Whole-body X-ray CT System (K171738)
Regulation Number:21 CFR 892.1750
Regulation Name:Computed tomography x-ray system
Product CodeJAK, System, X-Ray, Tomography, Computed
ClassII
PanelRadiology

Indications for Use

The Supria True64 system is indicated for head, whole body, and vascular X-ray Computed Tomography applications in patients of all ages. The images can be acquired in either axial, helical, or dynamic modes.

The volume datasets acquired by the Supria can be post processed by the system to provide additional information. Post processing capabilities included in the Supria software include CT angiography (CTA), Multi-planar reconstruction (MPR) and volume rendering. Volume datasets acquired by the Supria can be transferred to external devices via a DICOM standard interface. The guideShot Option adds a remote in-room display and controls to support interventional imaging. The device output can provide an aid to diagnosis when used by a qualified physician.

Device Description

Function

The Supria True64 is a multi-slice computed tomography system designed to perform multi-slice CT scanning supported by 64-detector technology. The system allows optimum clinical applications ranging from routine exams in response to the diversified circumstances in imaging whole body regions.

4

Image /page/4/Picture/0 description: The image shows the Hitachi logo. The word "HITACHI" is in bold, black letters on the top line. The words "Inspire the Next" are in a smaller, black font on the second line. There is a red accent mark above the letter "t" in the word "Next".

Scientific Concepts

The Supria True64 system uses 64-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator, X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles.

The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system.

Physical and Performance Characteristics

The Supria True64 system consists of a Gantry, Operator's Workstation, Patient Table, High-Frequency X-ray Generator, and accessories. The system performance is similar to the predicate device.

Performance Comparison

As part of our design validation, performance comparison analysis was conducted to demonstrate continued conformance with a special control or recognized standard.

No new hazards were identified with the Supria True64 with ECG Prospective Scan (Axial). The subject device has been evaluated for effectiveness, electromagnetic compatibility, as well as electrical and mechanical safety, and have been found to conform to applicable medical device safety standards.

Testing TypeRationale Analysis
Validation Testing - BenchBased on the results of the ECG Prospective Scan Performance Testing Report contained in Verification and Validation
Documentation of Section 9, Hitachi judged that Supria True64 with ECG Prospective Scan (Axial) performs to
specifications.
Validation Testing - ClinicalNone required

The analysis confirms the performance characteristics of the Supria True64 are comparable to the predicate device and support our conclusion that the subject system is substantially equivalent to Supria True64 Whole-body X-ray CT System (K171738).

Device Technological Characteristics

The technological characteristics of the Supria True64 and the predicate device are listed in Table 1 Technological Characteristic Differences.

ITEMSupria True64Supria True64 (K171738)Difference
Gantry
GeometryRotate-rotate with offset detector system, slip ringRotate-rotate with offset detector system, slip ringNo
Scan Time0.75, 1.0, 1.5, 2.0 [s]0.75, 1.0, 1.5, 2.0 [s]No
X-ray Fan Beam Angle51 [deg]51 [deg]No
Gantry Tilt-30 to +30 [deg]-30 to +30 [deg]No
Gantry Aperture750 [mm]750 [mm]No
Gantry Dimensions1990 x 920 x 1842.5 [mm]1990 x 920 x 1842.5 [mm]No
Gantry Weight1600 [kg]1600 [kg]No
Scan LocalizerLaserLaserNo
Detector
TypeSolid stateSolid stateNo
ITEMSupria True64Supria True64 (K171738)Difference
Number of Channels880 [ch] (16 slice)
888 [ch] (64 slice)880 [ch] (16 slice)
888 [ch] (64 slice)No
Number of Rows16 (16 slice)
64 (64 slice)16 (16 slice)
64 (64 slice)No
Number of Slices16 [slice/scan] (Axial) (16 slice)
64 [slice/scan] (Axial) (64 slice)16 [slice/scan] (Axial) (16 slice)
64 [slice/scan] (Axial) (64 slice)No
X-ray Tube
Anode Heat Storage5 [MHU]5 [MHU]No
Dissipation Rate470 [kHU/min]470 [kHU/min]No
Tube coolingOil/airOil/airNo
Tube focal spotDual 0.7 x 0.8, 1.2 x 1.4 [mm]Dual 0.7 x 0.8, 1.2 x 1.4 [mm]No
X-ray Generator
kW OutputSystem Maximum 48[kW] /
Generator Maximum 51 [kW]System Maximum 48[kW] /
Generator Maximum 51 [kW]No
Max. Power Input75 [kVA]75 [kVA]No
kVp Range80, 100, 120, 140 [kVp]80, 100, 120, 140 [kVp]No
mA Range10 to 400 [mA] @120kV, 48kW10 to 400 [mA] @120kV, 48kWNo
Patient Table
Range of Movement,
Vertical450 to 1000 [mm] (CT-WT-21)450 to 1000 [mm] (CT-WT-21)No
Range of Movement,
Longitudinal1910 [mm] (CT-WT-21)1910 [mm] (CT-WT-21)No
Range of Movement,
LateralN/AN/ANo
Scannable Range155 cm155 cmNo
Maximum Load
Capacity227 [kg]227 [kg]No
Display
Monitor Type24" LCD24" LCDNo
Matrices, Pixels1920 x 12001920 x 1200No
Image EnlargementsUp to 9.99xUp to 9.99xNo
Max. Slices Displayed
at Once2525No
Image Storage
Hard Disk110 [GB] (images),
200 [GB] (raw data) (16 slice)
800 [GB] (raw data) (64 slice)110 [GB] (images),
200 [GB] (raw data) (16 slice)
800 [GB] (raw data) (64 slice)No
Storage Images200,000200,000No
Archival Storage
(Media)DVD-R/RW, CD-R/RWDVD-R/RW, CD-R/RWNo
Scanning, Reconstruction
Localization ScanReal timeReal timeNo
Localization Scan
Length150, 250, 350, 500, 750,
1000, 1250, 1500, 1750 [mm]150, 250, 350, 500, 750,
1000, 1250, 1500, 1750 [mm]No
Max. Scan Time100 [s]100 [s]No
Helical Beam Pitch0.56, 0.81, 1.06, 1.31, 1.56 (16 slice)
0.58, 0.83, 1.08, 1.33, 1.58 (64 slice)0.56, 0.81, 1.06, 1.31, 1.56 (16 slice)
0.58, 0.83, 1.08, 1.33, 1.58 (64 slice)No
Collimation1.25, 5, 10, 15, 20 [mm]1.25, 5, 10, 15, 20 [mm]No
Reconstruction Matrix512 x 512 [pix]512 x 512 [pix]No
Reconstruction FOVs20 to 500 [mm]20 to 500 [mm]No
Slice Thickness0.625, 1.0, 1.25, 2.5, 3.75,
5.0, 7.5, 10.0 [mm]0.625, 1.0, 1.25, 2.5, 3.75,
5.0, 7.5, 10.0 [mm]No
Range of CT numbers-2000 to +4000 (13bit)
-32768 to +32767 (16bit)-2000 to +4000 (13bit)
-32768 to +32767 (16bit)No
ITEMSupria True64Supria True64 (K171738)Difference
Reconstruction Time0.1 seconds per image or less0.1 seconds per image or lessNo
Performance
High-contrast spatial
resolution0.35 [mm]0.35 [mm]No
Low-contrast resolution
mm at % at ≤4 rads2.5 [mm] @ 0.25%2.5 [mm] @ 0.25%No
10% MTF14.7 [lp/cm]14.7 [lp/cm]No
50% MTF12.2 [lp/cm]12.2 [lp/cm]No
Dose Controls
Bow Tie FilterYes. NormalYes. NormalNo
Automatic Exposure
ControlYes. IntelliECYes. IntelliECNo
Longitudinal ModulationYesYesNo
Angular ModulationYesYesNo
Iterative ReconstructionYes. Intelli IP Advanced, Intelli IP QuickYes. Intelli IP Advanced, Intelli IP QuickNo
Maximum possible pitch1.56 (16 slice)1.56 (16 slice)No
with full image quality1.58 (64 slice)1.58 (64 slice)No
Dose Displays
CTDIvYesYesNo
DLPYesYesNo
Features
Axial ScanYesYesNo
Helical ScanYesYesNo
Dynamic ScanYesYesNo
Predict ScanYesYesNo
ECG Retrospective
Scan
(Helical)NoNoNo
ECG Prospective Scan
(Axial)YesNoSee 01
guideShot ScanYesYesNo
Automatic Exposure
ControlYesYesNo
Automatic Exposure
Control using Iterative
ReconstructionNoNoNo
ECG Dose ModulationNoNoNo
Adaptive FilterNoNoNo
Iterative ReconstructionYes. Intelli IP Advanced, Intelli IP QuickYes. Intelli IP Advanced, Intelli IP QuickNo
Injector SynchronizationYesYesNo
Dose CheckYesYesNo
Access ControlYesYesNo
Automatic Cardiac
Phase SearchNoNoNo
Preview ScanNoNoNo
Double Slice at Axial
ScanNoNoNo
Priority Recon.NoNoNo
Dose ReportYes. Simple Dose ReportYes. Simple Dose ReportNo
DICOMYesYesNo
ID ReaderYesYesNo
Exam SplitYesYesNo
Multi-Planar
Reconstruction (MPR)YesYesNo
ITEMSupria True64Supria True64 (K171738)Difference
Volume RenderingYesYesNo
CT Angiography (CTA)YesYesNo
SegmentationYesYesNo
RetouchYesYesNo
Quality ExamYesYesNo
HiMARYesYesNo
Orbit synchronization
scanYesYesNo
Off-time modeYesYesNo
On-time standbyYesYesNo
Shutter Scan ReductionYesYesNo

Table 1 Technological Characteristic Differences

@Hitachi Healthcare Americas

1959 Summit Commerce Park, Twinsburg, OH 44087 Tel:800-800-3106 www.hitachimed.com

5

@Hitachi Healthcare Americas
1959 Summit Commerce Park, Twinsburg, OH 44087 Tel:800-800-3106
www.hitachimed.com

6

@Hitachi Healthcare Americas
1959 Summit Commerce Park, Twinsburg, OH 44087 Tel:800-800-3106
www.hitachimed.com

7

Image /page/7/Picture/0 description: The image shows the Hitachi logo. The word "HITACHI" is in bold, black letters. Below it, in a smaller font, is the phrase "Inspire the Next" in black letters.

The differences from the predicate device to the subject device are explained below table.

Feature
01ECG Prospective Scan (Axial): scanning can be performed in synchronization with ECG trigger signal

ECG Prospective Axial Scan feature was originally cleared on the HITACHI SCENARIA Wholebody X-ray CT System (K101888).

Therefore, based on a thorough analysis and comparison of subject device (Supria True64) and the predicate device, the technological characteristics do not impact safety and effectiveness.

Substantial Equivalence

A summary decision was based on analysis of Table 2.

Table 2 Rationale Analysis: Subject vs. Predicate Device
ITEMOverall Rationale Analysis
GantryThere are no significant changes in technology characteristics, hardware, and software from the predicate device, Supria True64 Whole-body X-ray CT System (K171738).
Detector
X-ray Tube
X-ray Generator
Patient Table
Display
Image Storage
Scanning, Reconstruction
Performance
Dose Controls
Dose Displays
Features

Table 2 Rationale Analysis: Subiect vs. Predicate Device

Therefore, based on a thorough analysis and comparison of the functions, scientific concepts. physical and performance characteristics, performance comparison and technological characteristics, the proposed Supria True64 Whole-body X-ray CT System is considered substantially equivalent to the currently marketed predicate device (Supria True64 Whole-body X-ray CT System (K171738)) in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness.

8

Image /page/8/Picture/0 description: The image shows the Hitachi logo. The word "HITACHI" is written in large, bold, black letters. Below the word "HITACHI" is the phrase "Inspire the Next" in a smaller, black font. There is a small red accent mark above the letter "t" in the word "Next".

Summary of Non-Clinical Testing

This device complies with all applicable requirements for Dose Profile. Noise. Mean CT number and Uniformity, Spatial Resolution, Tomographic Section Thickness and Sensitivity Profile, Tomographic Plane Location, and CT dose index. Adding the ECG Prospective Scan (Axial) would not impact the results of the testing done in the original submission.

Noise, Mean CT number, Uniformity and Spatial Resolution test results for the Supria True64 Whole-body X-ray CT System (K171738) would not be effected by this feature.

In addition, the Supria True64 system is in conformance with the applicable parts of the following standards:

  • AAMI ANSI ES60601-1:2005/(R) 2012 and A1:2012, C1:2009/(R)2012 and . A2:2010/(R)2012
    Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD)

  • IEC 60601-1-2 Edition 3: 2007 . Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests

  • IEC 60601-1-3 Edition 2.0 2008-01

Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment

  • IEC 60601-2-44 Edition 3.0 2009-02 ● Medical electrical equipment Part 2-44: particular requirements for the basic safety and essential performance of x-ray equipment for computed tomography.
  • NEMA XR 25 Computed Tomography Dose Check ●
  • NEMA XR26 Access Controls for Computer Tomography: Identification. Interlocks, and Logs ●
  • IEC 62304 First edition 2006-05. Medical device software Software life cycle processes .

In addition, the ECG Prospective Scan feature was subject to performance tests, which confirmed that the X-ray was in synchronization with the ECG trigger and the acquired images. The results confirmed that images which are synchronized with ECG R-wave signal can be acquired by using ECG Prospective Scan.

Summary of Clinical Testing

Based on verification and validation results and analysis of the additional feature, Hitachi believes clinical testing was not required.

Conclusions

The results of the performance testing, the validation and the electromagnetic compatibility electrical safety testing demonstrate that the proposed Supria True64 Whole-body X-ray CT System with ECG Prospective Axial Scan meets the acceptance criteria and is adequate for its intended use.

In addition, the risk analysis demonstrate that all risks are sufficiently mitigated, that no new risks are introduced, and the overall residual risks are acceptable.

Based on the supporting data provided in this submission, the proposed Supria True64 Wholebody X-ray CT System with ECG Prospective Axial Scan is considered substantially equivalent to the predicate device in terms of safety and effectiveness. There are no significant differences that may raise new issues of safety or effectiveness. Bench tests and user validation have been

9

Image /page/9/Picture/0 description: The image contains the Hitachi logo. The word "HITACHI" is written in large, bold, black letters. Below the logo, the words "Inspire the Next" are written in a smaller, less bold font. The word "Next" has a red accent mark above the letter "e".

performed to demonstrate that the subject system is as safe and effective as the predicate device, without raising any new safety and/or effectiveness concerns.